Swedish Cancer Institute’s Dr. Thomas Brown receives Pioneer in Precision, Personalized Cancer Therapy Award
October 28, 2016
Recently, Dr. Thomas Brown, MBA, executive director of the Swedish Cancer Institute and co-chair of the Cancer Leadership Council for Providence Health & Services, received the Pioneer in Precision, Personalized Cancer Therapy Award for contributions in the field of oncology from the Personalized Lifestyle Medicine Institute. Dr. Brown was one of five recipients.
The award ceremony took place on Oct. 22 at the 4th Annual Thought Leaders Consortium in Phoenix, Arizona. Other award recipients include Edward Lin, M.D., chief medical officer of P4Medicine Institute, and Susan Snodgrass, M.D., senior medical director at Juno Therapeutics.
The Personalized Lifestyle Medicine Institute (PLMI) is a Seattle-based not-for-profit entity whose mission is to transform healthcare through the promotion of information, innovation, and implementation of personalized lifestyle medicine. For more information about PLMI, visit http://plminstitute.org.